Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Haematologica. - 106, 3 (2021) , 9750, ISSN: 1592-8721
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2020
- Creator
-
Woerner, Sandra Maria
Möller, Mandy-Deborah
Ihorst, Gabriele
Langer, Christian
Pönisch, Wolfram
Mügge, Lars-Olof
Knop, Stefan
Jung, Johannes
Greil, Christine
Wäsch, Ralph
Engelhardt, Monika
- DOI
-
10.3324/haematol.2020.254235
- URN
-
urn:nbn:de:bsz:25-freidok-1699987
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Woerner, Sandra Maria
- Möller, Mandy-Deborah
- Ihorst, Gabriele
- Langer, Christian
- Pönisch, Wolfram
- Mügge, Lars-Olof
- Knop, Stefan
- Jung, Johannes
- Greil, Christine
- Wäsch, Ralph
- Engelhardt, Monika
- Universität
Time of origin
- 2020
Other Objects (12)
Response to daratumumab-retreatment in patients with multiple myeloma
Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial
Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long‐term follow‐up of 815 patients
Clinical characteristics, cytogenetic risks, and prognoses of young multiple myeloma patients in the era of novel therapies
Allogeneic stem cell transplantation in multiple myeloma
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Myosteatosis in multiple myeloma: a key determinant of survival beyond sarcopenia
Myosteatosis in multiple myeloma: a key determinant of survival beyond sarcopenia
Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age
Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional study
Response to daratumumab-retreatment in patients with multiple myeloma
Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial
Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long‐term follow‐up of 815 patients
Clinical characteristics, cytogenetic risks, and prognoses of young multiple myeloma patients in the era of novel therapies
Allogeneic stem cell transplantation in multiple myeloma
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Myosteatosis in multiple myeloma: a key determinant of survival beyond sarcopenia
Myosteatosis in multiple myeloma: a key determinant of survival beyond sarcopenia
Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age
Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional study
Response to daratumumab-retreatment in patients with multiple myeloma
Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial
Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long‐term follow‐up of 815 patients
Clinical characteristics, cytogenetic risks, and prognoses of young multiple myeloma patients in the era of novel therapies
Allogeneic stem cell transplantation in multiple myeloma
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Myosteatosis in multiple myeloma: a key determinant of survival beyond sarcopenia
Myosteatosis in multiple myeloma: a key determinant of survival beyond sarcopenia
Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age